HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Label Warnings Against Driving Start Arriving For OTC Sleep Ingredients In US

Executive Summary

Unisom Sleeptab with 25 mg doxylamine is first OTC sleep remedy adding warning not to drive a vehicle or operate machinery and five others FDA requested in “changes being effected” letter. Agency’s ongoing review found “labeling deficiencies” with doxylamine and diphenhydramine.

You may also be interested in...



Vicks Pure Zzzs offer a natural nights sleep

Sleep soundly and wake up refreshed is the message to US consumers as Procter & Gamble (P&G) ramps up marketing behind its recently launched ZzzQuil Pure Zzzs gummies.

OTC Sleep Aid Sales Snooze As Consumers Wake Up To Alternatives

Natural products cut into sales of OTC sleep aids as more consumers prefer naturals as non-addictive and not causing grogginess the following day, Kline & Co. research shows. OTC sleep aids posted 3.4% growth in 2016, down from 50% to 15% growth in recent years.

Consumer Health Care New Products Roundup: Unisom SleepMinis, Wolfshot

Unisom line extends with SleepMinis; Wolfshot energy tests in US and Canada; Clif Bar launches seasonal flavor; Mediterra adds savory bars; and more news in in brief

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153197

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel